会议日程
Friday, August 24th, 2007

07.00 – 16.00

RE – REGISTRATION

DKP Lobby

 

07.30 – 08.30

MEET THE EXPERT 1
Basic Hepatology - 1
(Discovery Room)

MEET THE EXPERT 2
CPC
(Arjuna Room)

 

MEET THE EXPERT 3
CLINICAL SIGNIFICANT OF HBV GENOTYPE: RECENT STUDIES
(Kharisma Room)

Chairmen

Jin-lin Hou, China
Julius, Indonesia

Guang-bi yao, China
Wirasmi Marwoto, Indonesia

Lai Wei, China
Rino A. Gani, Indonesia

07.30 – 07.40

Polymorphism analyses of hepatitis B virus X gene in HCC patients and the biological effects of truncated HBx on QSG7701 cell line
De-Ming Tan, China

Case Presentation

 

 

Wirasmi Marwaoto, Indonesia

Natural history of HBV infections related to genotype in Asia
Ali Sulaiman, Indonesia

07.40 – 07.50

Cancer is a systems disease characterized by cell growth abnormality of defined tissues or organs
Jian-ren Gu, China
(previous : Systematic Approach on Human Hepato Cellular Carcinoma)

Management of Gastro-esophageal Variceal Bleeding
Ji-Yao Wang,, China
(previous : The management of esophageal gastric variceal bleeding)

Advances in HBV Genotype Studies
Tong Li, China
(previous : Advances in HBV genotype studies)

07.50 – 08.00

Study on the expression of toll-like receptor 3 (TLR3) on dendritic cells derived from peripheral blood monocyte of chronic hepatitis B patients
Guang-Feng Shi, China

Cholestasis (for Children)
Ening Krisnuhoni, Indonesia

__________________________
Rino A. Gani, Indonesia

08.00 – 08.30

DISCUSSION

DISCUSSION

DISCUSSION

08.30 – 09.30

STATE OF THE ART LECTURE 1 – 2 (STAL)
(Kharisma Room)

Chairmen

Zhong-ping Duan, China

Sjaifoellah Noer, Indonesia

08.30 – 08.55

Prevalence and prevention of Hep- B in China
Hui Zhuang, China
(previous : Seroprevalence of HBV infection in China)

08.55 – 09.20

Hepatic Resection for HCC and Metastatic Tumor
Masatoshi Makuuchi, Japan

09.20 – 09.30

DISCUSSION

09.30 – 10.30

OPENING CEREMONY: PRESIDENT RI / M.O.H
Launching ILCF

Kharisma Room

10.30 – 11.00

COFFEE BREAK & VISIT EXHIBITION

11.00 – 12.30

SPONSORED SYMPOSIUM 1
ADDRESING CHALLENGES IN eAg NEGATIVE MANAGEMENT
Kharisma Room

Chairmen

Guang-Feng Shi, China
Poernomo Budi, Indonesia

11.00? - ?11.25

eAg Negative: disease progression
Yan Yan Yu, China

11.25 – 11.45

Managing eAg Negative CHB
L.A. Lesmana, Indonesia

11.45 – 12.30

DISCUSSION

12.30 – 14.00

FRIDAY PRAYER, LUNCH, POSTER SESSION & EXHIBITION(GL Lobby)

 

14.00 – 15.00

SPONSORED SYMPOSIUM 2
TREATMENT OPTIONS FOR ADVANCED HCC
Kharisma Room

Chairmen

M. Omata, Japan Ali Sulaiman, Indonesia

14.00 – 14.15

HCC : Past and Present Treatment Nurul Akbar, Indonesia

14.15 – 14.40

Novel Treatment for Advanced HCC Pierce Chow, Singapore

14.40 – 15.00

DISCUSSION

15.00 – 15.30

COFFEE BREAK & VISIT EXHIBITION

 

15.30 – 16.30

SYMPOSIUM 1
EMERGENCIES IN HEPATOLOGY
(Kharisma Room)

SYMPOSIUM 2
MINIMALLY INVASIVE SURGERY IN HEPATOBILIARY DISORDERS
(Discovery Room)

Chairmen

Qin-huan Wang, China
Unggul Budihusodo, Indonesia

Hermansyur K., Indonesia
Shi-chun Lu, China

15.30 – 15.45

Treatment of Hepatorenal Syndrome
Lukman Hakim, Indonesia
(previous : Evidence Based Treatment of Hepatorenal Syndrome)

Laparoscopic Liver Resection for Benign and Malignant Tumours
Pierce Chow, Singapore

15.45 – 16.00

Fulminant Hepatic Failure : from basic science to therapeutic intervention
Qin Ning, China
(previous : Fulminant viral hepatitis : from basic science to therapeutic intervention)

Laparoscopic common bile duct exploration (LCBDE)
Errawan Wiradisuria, Indonesia

16.00 – 16.15

Current Treatment of Hepatic Encephalopathy
I.D.N. Wibawa, Indonesia

Effect of plasma exchange before Liver transplantation on the operation and prognosis of patients with chronic severe hepatitis : a report of 70 cases
Shi-Chun Lu, China

16.15 – 16.30

DISCUSSION

DISCUSSION

16.30 – 17.00

STATE OF THE ART LECTURE 3 (STAL) (Kharisma Room)
Chairmen : Azis Rani, Indonesia
Ling-xia Zhang, China

 

Primary Prophylaxis – for Variceal Bleeding
S. K. Sarin, India

 

 

 

17.30 – end

SUNSET & WELCOME RECEPTION
(Discovery Mall Exotic Beachside)

1 2 3 4